NCT06012435 2026-03-18
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Seagen Inc.
Phase 3 Active not recruiting
Seagen Inc.
Gilead Sciences
Genmab
Revolution Medicines, Inc.
Alliance for Clinical Trials in Oncology